JPMorgan Chase & Co’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134 | Sell |
|
|||||
|
2025
Q1 | $2.37K | Sell |
|
|||||
|
2024
Q4 | $3.43K | Buy |
|
|||||
|
2024
Q3 | $1.76K | Sell |
|
|||||
|
2024
Q2 | $4.89K | Sell |
|
|||||
|
2024
Q1 | $22.8K | Sell |
|
|||||
|
2023
Q4 | $248K | Sell |
|
|||||
|
2023
Q3 | $2.27M | Sell |
|
|||||
|
2023
Q2 | $3.72M | Buy |
|
|||||
|
2023
Q1 | $3.88M | Buy |
|
|||||
|
2022
Q4 | $4.94M | Buy |
|
|||||
|
2022
Q3 | $4.81M | Sell |
|
|||||
|
2022
Q2 | $3.03M | Buy |
|
|||||
|
2022
Q1 | $5.16M | Buy |
|
|||||
|
2021
Q4 | $7.74M | Sell |
|
|||||
|
2021
Q3 | $18.7M | Sell |
|
|||||
|
2021
Q2 | $15.9M | Buy |
|
|||||
|
2021
Q1 | $11.7M | Buy |
|
|||||
|
2020
Q4 | $310K | Buy |
|
|||||
|
2020
Q3 | $180K | Buy |
|